General Information of the Compound
Compound ID
CP0396742
Compound Name
4-[4-(5-bromo-4-chloroimidazol-1-yl)-1,3-thiazol-2-yl]morpholine
    Show/Hide
Structure
Formula
C10H10BrClN4OS
Molecular Weight
349.641
Canonical SMILES
Clc1ncn(-c2csc(n2)N2CCOCC2)c1Br
    Show/Hide
InChI
InChI=1S/C10H10BrClN4OS/c11-8-9(12)13-6-16(8)7-5-18-10(14-7)15-1-3-17-4-2-15/h5-6H,1-4H2
    Show/Hide
InChIKey
CHYLBZAFNCKKHM-UHFFFAOYSA-N
Physicochemical Property
logP
2.5813
Rotatable Bonds
2
Heavy Atom Count
18
Polar Areas
43.18
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
18

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 118314654
ChEMBL ID
CHEMBL3323489
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00894, Androgen receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000141 LNCaP Homo sapiens (Human)  2
1
IC50 = 330 nM
   TI
   LI
   LO
   TS
2
IC50 = 440 nM
   TI
   LI
   LO
   TS